SyqeAir is making waves! We’re proud to share that Israel21c has recognized the SyqeAir Inhaler as one of the 12 most amazing Israeli medical advances.
This honor highlights our innovative work in medical cannabis treatment, delivering a metered-dose, safe, and effective solution for patients living with chronic neuropathic pain and PTSD to allow them to maintain an optimal daily routine and improve their quality of life.
Eight Years And $83 Million Later, Syqe® Medical Releases First Cannabis Inhaler
Teva will market the company’s inhalers exclusively in Israel, after signing a marketing and distribution agreement with Syqe® in 2016.